Medications for Neurofibromatosis 1

2 results

  • gomekli

    (mirdametinib)
    SpringWorks Therapeutics, Inc.
    GOMEKLI is indicated for the treatment of adult and pediatric patients aged 2 and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) that cannot be completely resected.

  • koselugo

    (SELUMETINIB)
    AstraZeneca Pharmaceuticals LP
    KOSELUGO is indicated for the treatment of pediatric patients aged 2 and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas.